| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01add3ae409b1925f37b784f7fa149f0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2009-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8999a0a6a929a4d9ba1ff85082feec50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_083da2b7a17c5731102fe092519049ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29e43d1b95ff79521d4ed8528cf6baed |
| publicationDate |
2009-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009233299-A1 |
| titleOfInvention |
Physiogenomic Method for Predicting Statin Injury to Muscle and Muscle Side Effects |
| abstract |
The present invention relates to the use of genetic variants of associated marker genes to predict an individual's susceptibility to muscular injury and muscular side effects in response to statin therapy. The present invention further relates to analytical assays and computational methods using the novel marker gene set. The present invention has utility for personalized medical treatment, drug safety, statin compliance, and prophylaxis of muscle side effect. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2479869-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11468355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11216742-B2 |
| priorityDate |
2005-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |